228 related articles for article (PubMed ID: 16822563)
21. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
22. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
[TBL] [Abstract][Full Text] [Related]
23. Platelet activation in acute, decompensated congestive heart failure.
Chung I; Choudhury A; Lip GY
Thromb Res; 2007; 120(5):709-13. PubMed ID: 17287016
[TBL] [Abstract][Full Text] [Related]
24. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
[TBL] [Abstract][Full Text] [Related]
25. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
26. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
Doumas M; Tsakiris A; Douma S; Grigorakis A; Papadopoulos A; Hounta A; Tsiodras S; Dimitriou D; Giamarellou H
Asian J Androl; 2006 Mar; 8(2):177-82. PubMed ID: 16491268
[TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
29. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
30. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
[TBL] [Abstract][Full Text] [Related]
32. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
33. [Use of nebivolol in patients with mild and moderate hypertension].
Zhigunova LV; Lakhova EL; Iurenev AP
Ter Arkh; 2003; 75(3):59-61. PubMed ID: 12718224
[TBL] [Abstract][Full Text] [Related]
34. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
[TBL] [Abstract][Full Text] [Related]
36. Lifestyle modification decreases the mean platelet volume in prehypertensive patients.
Yazici M; Kaya A; Kaya Y; Albayrak S; Cinemre H; Ozhan H
Platelets; 2009 Feb; 20(1):58-63. PubMed ID: 19172523
[TBL] [Abstract][Full Text] [Related]
37. Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women.
Preston RA; Afshartous D; Materson BJ; Rodco R; Alonso AB
Hypertension; 2014 Aug; 64(2):287-95. PubMed ID: 24842917
[TBL] [Abstract][Full Text] [Related]
38. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
Nadar SK; Blann AD; Lip GY
J Intern Med; 2004 Oct; 256(4):331-7. PubMed ID: 15367176
[TBL] [Abstract][Full Text] [Related]
39. Soluble P-selectin as a marker of in vivo platelet activation.
Ferroni P; Martini F; Riondino S; La Farina F; Magnapera A; Ciatti F; Guadagni F
Clin Chim Acta; 2009 Jan; 399(1-2):88-91. PubMed ID: 18835553
[TBL] [Abstract][Full Text] [Related]
40. In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients.
Ferroni P; Martini F; D'Alessandro R; Magnapera A; Raparelli V; Scarno A; Davì G; Basili S; Guadagni F
Clin Chim Acta; 2008 Feb; 388(1-2):33-7. PubMed ID: 18001701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]